Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Barinthus Biotherapeutics (BRNS) Gains from Sales and Divestitures (2021)

Historic Gains from Sales and Divestitures for Barinthus Biotherapeutics (BRNS) over the last 1 years, with Q4 2021 value amounting to $514923.0.

  • Barinthus Biotherapeutics' Gains from Sales and Divestitures changed N/A to $514923.0 in Q4 2021 from the same period last year, while for Dec 2021 it was $514923.0, marking a year-over-year change of. This contributed to the annual value of $514923.0 for FY2021, which is N/A changed from last year.
  • As of Q4 2021, Barinthus Biotherapeutics' Gains from Sales and Divestitures stood at $514923.0.
  • In the past 5 years, Barinthus Biotherapeutics' Gains from Sales and Divestitures registered a high of $514923.0 during Q2 2021, and its lowest value of $514923.0 during Q2 2021.